L C Bell1, M D Does2, A M Stokes1, L C Baxter1, K M Schmainda3, A C Dueck4, C C Quarles5. 1. From the Division of Imaging Research (L.C. Bell, A.M.S., L.C. Baxter, C.C.Q.), Barrow Neurological Institute, Phoenix, Arizona. 2. Department of Biomedical Engineering (M.D.D.), Vanderbilt University Institute of Imaging Science, Nashville, Tennessee. 3. Departments of Biophysics and Radiology (K.M.S.), Medical College of Wisconsin, Milwaukee, Wisconsin. 4. Division of Health Sciences Research (A.C.D.), Section of Biostatistics, Mayo Clinic, Scottsdale, Arizona. 5. From the Division of Imaging Research (L.C. Bell, A.M.S., L.C. Baxter, C.C.Q.), Barrow Neurological Institute, Phoenix, Arizona chad.quarles@barrowneuro.org.
Abstract
BACKGROUND AND PURPOSE: The optimal TE must be calculated to minimize the variance in CBV measurements made with DSC MR imaging. Simulations can be used to determine the influence of the TE on CBV, but they may not adequately recapitulate the in vivo heterogeneity of precontrast T2*, contrast agent kinetics, and the biophysical basis of contrast agent-induced T2* changes. The purpose of this study was to combine quantitative multiecho DSC MRI T2* time curves with error analysis in order to compute the optimal TE for a traditional single-echo acquisition. MATERIALS AND METHODS: Eleven subjects with high-grade gliomas were scanned at 3T with a dual-echo DSC MR imaging sequence to quantify contrast agent-induced T2* changes in this retrospective study. Optimized TEs were calculated with propagation of error analysis for high-grade glial tumors, normal-appearing white matter, and arterial input function estimation. RESULTS: The optimal TE is a weighted average of the T2* values that occur as a contrast agent bolus transverses a voxel. The mean optimal TEs were 30.0 ± 7.4 ms for high-grade glial tumors, 36.3 ± 4.6 ms for normal-appearing white matter, and 11.8 ± 1.4 ms for arterial input function estimation (repeated-measures ANOVA, P < .001). CONCLUSIONS: Greater heterogeneity was observed in the optimal TE values for high-grade gliomas, and mean values of all 3 ROIs were statistically significant. The optimal TE for the arterial input function estimation is much shorter; this finding implies that quantitative DSC MR imaging acquisitions would benefit from multiecho acquisitions. In the case of a single-echo acquisition, the optimal TE prescribed should be 30-35 ms (without a preload) and 20-30 ms (with a standard full-dose preload).
BACKGROUND AND PURPOSE: The optimal TE must be calculated to minimize the variance in CBV measurements made with DSC MR imaging. Simulations can be used to determine the influence of the TE on CBV, but they may not adequately recapitulate the in vivo heterogeneity of precontrast T2*, contrast agent kinetics, and the biophysical basis of contrast agent-induced T2* changes. The purpose of this study was to combine quantitative multiecho DSC MRI T2* time curves with error analysis in order to compute the optimal TE for a traditional single-echo acquisition. MATERIALS AND METHODS: Eleven subjects with high-grade gliomas were scanned at 3T with a dual-echo DSC MR imaging sequence to quantify contrast agent-induced T2* changes in this retrospective study. Optimized TEs were calculated with propagation of error analysis for high-grade glial tumors, normal-appearing white matter, and arterial input function estimation. RESULTS: The optimal TE is a weighted average of the T2* values that occur as a contrast agent bolus transverses a voxel. The mean optimal TEs were 30.0 ± 7.4 ms for high-grade glial tumors, 36.3 ± 4.6 ms for normal-appearing white matter, and 11.8 ± 1.4 ms for arterial input function estimation (repeated-measures ANOVA, P < .001). CONCLUSIONS: Greater heterogeneity was observed in the optimal TE values for high-grade gliomas, and mean values of all 3 ROIs were statistically significant. The optimal TE for the arterial input function estimation is much shorter; this finding implies that quantitative DSC MR imaging acquisitions would benefit from multiecho acquisitions. In the case of a single-echo acquisition, the optimal TE prescribed should be 30-35 ms (without a preload) and 20-30 ms (with a standard full-dose preload).
Authors: Benjamin M Ellingson; Taryar Zaw; Timothy F Cloughesy; Kourosh M Naeini; Shadi Lalezari; Sandy Mong; Albert Lai; Phioanh L Nghiemphu; Whitney B Pope Journal: J Magn Reson Imaging Date: 2012-01-26 Impact factor: 4.813
Authors: L S Hu; L C Baxter; K A Smith; B G Feuerstein; J P Karis; J M Eschbacher; S W Coons; P Nakaji; R F Yeh; J Debbins; J E Heiserman Journal: AJNR Am J Neuroradiol Date: 2008-12-04 Impact factor: 3.825
Authors: Mark W Woolrich; Saad Jbabdi; Brian Patenaude; Michael Chappell; Salima Makni; Timothy Behrens; Christian Beckmann; Mark Jenkinson; Stephen M Smith Journal: Neuroimage Date: 2008-11-13 Impact factor: 6.556
Authors: Antonio C M Maia; Suzana M F Malheiros; Antonio J da Rocha; João N Stávale; Iara F Guimarães; Lia R R Borges; Adrialdo J Santos; Carlos J da Silva; Julieta G S P de Melo; Oreste P Lanzoni; Alberto A Gabbai; Fernando A P Ferraz Journal: J Neurosurg Date: 2004-12 Impact factor: 5.115
Authors: Nasuda Danchaivijitr; Adam D Waldman; Daniel J Tozer; Christopher E Benton; Gisele Brasil Caseiras; Paul S Tofts; Jeremy H Rees; H Rolf Jäger Journal: Radiology Date: 2008-04 Impact factor: 11.105
Authors: Ashley M Stokes; Natenael B Semmineh; Ashley Nespodzany; Laura C Bell; C Chad Quarles Journal: Magn Reson Med Date: 2019-08-09 Impact factor: 4.668
Authors: Ashley M Stokes; Maurizio Bergamino; Lea Alhilali; Leland S Hu; John P Karis; Leslie C Baxter; Laura C Bell; C Chad Quarles Journal: J Cereb Blood Flow Metab Date: 2021-08-20 Impact factor: 6.960